Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neuronetics Inc.

3.71
-0.0100-0.27%
Volume:676.21K
Turnover:2.52M
Market Cap:244.19M
PE:-3.04
High:3.86
Open:3.79
Low:3.64
Close:3.72
Loading ...

Why Neuronetics Inc (STIM) Is Skyrocketing So Far In 2025

Insider Monkey
·
04 Feb

Neuronetics Inc : Canaccord Genuity Raises Target Price to $5 From $3

THOMSON REUTERS
·
03 Feb

Neuronetics Inc expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
31 Jan

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression

GlobeNewswire
·
29 Jan

Neuronetics (NASDAQ:STIM) shareholders are up 34% this past week, but still in the red over the last five years

Simply Wall St.
·
29 Jan

Neuronetics Inc expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
24 Jan

Neuronetics Inc expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
17 Jan

BRIEF-Neuronetics Provides Business Update And Issues 2025 Guidance

Reuters
·
13 Jan

Neuronetics Provides Business Update and Issues 2025 Guidance

THOMSON REUTERS
·
13 Jan

Neuronetics Inc - Expects 2025 Pro Forma Revenue Growth of 12%-19%

THOMSON REUTERS
·
13 Jan

Neuronetics Inc - Expects Cash Flow Breakeven in Q3 2025

THOMSON REUTERS
·
13 Jan

Press Release: Neuronetics Provides Business Update and Issues 2025 Guidance

Dow Jones
·
13 Jan

Neuronetics Inc expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
03 Jan

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
19 Dec 2024

BRIEF-Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
17 Dec 2024

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
17 Dec 2024

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
17 Dec 2024

Neuronetics and Greenbrook TMS Announce Closing of Transaction

GlobeNewswire
·
10 Dec 2024